Bioanalysis, Pharmaceutical Analysis, Stability Testing, Impurity Characterization and ...
Founded by a group of veterans from US biopharmaceutical industries in 2004, Sundia MediTech Company Ltd. is now a leading Shanghai-based pharmaceutical and biotech R&D out-sourcing company. Recently merged with United PharmaTech and formed alliance with HD Biosciences, Sundia offers broad and integrated services of custom organic synthesis, medicinal chemistry, process chemistry, APIs manufacturing under cGMP or non-cGMP, bioassay, and in vitro & in vivo PK studies. We have successfully established collaborations with over 60 client companies in North America, Europe, and Japan. Our professional team possesses talents from organic synthesis, medicinal chemistry, process chemistry, biology, to business management, and law. Sundia's management team members have received advanced degrees or training and have extensive working / management experiences in North America. Our research team comprises over 300 scientists, among which 18% are Ph.D.'s; 57% MS's; and 25% BS's.
News Center
2009-6-29
Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry more...
2009-6-25
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai more...
2009-6-16
Sundia's Animal Facility Passed Client and Government Inspection more...
2009-5-20
Finland Biotech Delegation Visit to Sundia more...
2009-4-7
Dr. Xiaochuan Wang, CEO of Sundia MediTech gave presentation in Zhangjiang Special Seminar, China 2009 Pharmaceutical R&D Summit on April 6, 2009 in Shanghai more...
2009-2-11
Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List more...
Copyright 2007 Sundia MediTech Company, LTD. All Rights Reserved